Address
9713 Key West Avenue
Rockville, MD 20850
United States of America (the)
Phone
301 944 1700
Website
Sector
Healthcare
Industry
Biotechnology
Employees
91
First IPO Date
July 29, 2021
| Name | Title | Pay | Year Born |
| Maher Masoud | President, Chief Executive Officer & Executive Director | 919,082 | 1976 |
| Parmeet Ahuja | Chief Financial Officer | 700,557 | 1969 |
| Ana-Paula Martins Fernandes | Senior Vice President of Global Sales | 0 | N/A |
| Jill Mayer | Senior Vice President of Human Resources | 0 | N/A |
| Jay Gelfman | Chief Operations Officer | 0 | N/A |
| Jack Horgan | Senior Vice President of Corporate Development | 0 | N/A |
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.